ELV
Elevance Health, Inc. · Finance & Insurance · Market cap $94.1B
Insiders bought $1.4M net in the last 90 days ·0 sellers, 2 buyers· latest Form 4 filed Jul 17, 2026
Insider Buying
$2.2M
reported purchases (SEC code P)
Insider Selling
$1.7M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Oct 6, 2026
BOUDREAUX GAIL
Elevance Health, Inc. (ELV) has 32 SEC Form 4 filings (61 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Oct 6, 2026.
Inside the rolling window, 7 insiders at Elevance Health, Inc. reported 3 open-market purchases totaling $2.2M and 5 open-market sales totaling $1.7M. Insiders have net bought $542K over the trailing 6 months. The largest single insider purchase in this window was $1.0M by President and CEO BOUDREAUX GAIL on Jul 17, 2026.
- Industry:Medical - Healthcare Plans
- CEO:Gail Koziara Boudreaux
- Employees:96,615
- HQ:Indianapolis, IN, US
- IPO:2001-10-30
| Source | |||||||
|---|---|---|---|---|---|---|---|
BOUDREAUX GAILFirst filing | President and CEO | Purchase | 2,725 | $1.0M | Jul 17 | +16.4% | SEC ↗ |
| Director | Purchase | 1,000 | $366K | Jul 17 | +16.4% | SEC ↗ | |
| CAO & Controller | Sale | 369 | $149K | Jun 15 | +8.0% | SEC ↗ | |
Dixon Robert L JRFirst filing | Director | Sale | 151 | $61K | Jun 12 | +7.4% | SEC ↗ |
Penczek Ronald WFirst filing | CAO & Controller | Sale | 1,531 | $617K | May 20 | +9.6% | SEC ↗ |
SCHULMAN AMY WFirst filing | Director | Sale | 26 | $7K | Mar 23 | +50.1% | SEC ↗ |
Kendrick Charles Morgan JRFirst filing | EVP & President, Commercial | Sale | 3,196 | $911K | Mar 9 | +54.6% | SEC ↗ |
| Director | Purchase | 3,000 | $870K | Mar 6 | +49.9% | SEC ↗ |
Congress trading ELV 87 all-time
- DRep. Ro KhannaSale$1,001 - $15,0002026-01-29
- RSen. Markwayne MullinPurchase$15,001 - $50,0002025-12-29
- RSen. Markwayne MullinPurchase$15,001 - $50,0002025-12-29
- DRep. Ro KhannaPurchase$1,001 - $15,0002025-09-29
- DRep. Ro KhannaPurchase$1,001 - $15,0002025-09-05
- RRep. Michael T. McCaulExchange$100,001 - $250,0002024-03-25
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does ELV have?
Elevance Health, Inc. (ELV) has 32 SEC Form 4 filings (61 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Oct 6, 2026.
When was the most recent SEC Form 4 filing for ELV?
The most recent Form 4 filing for ELV on Tracefour is dated Oct 6, 2026.
What is the net insider flow at ELV over the last 6 months?
Over the trailing 180 days, insiders at ELV have net bought $542K based on SEC Form 4 disclosures.
What was the largest insider purchase at ELV?
The largest single insider open-market purchase at ELV in the rolling window was $1.0M by President and CEO BOUDREAUX GAIL on 2026-07-17.
What is the total insider buy and sell value at ELV in the current window?
Inside the rolling window, insiders at ELV bought $2.2M and sold $1.7M based on SEC Form 4 filings.
Can I get alerts for ELV insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Elevance Health, Inc. (ELV). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Elevance Health, Inc. is in the Finance & Insurance sector.